300 related articles for article (PubMed ID: 21470278)
41. [Management of osteoporosis in patients with inhaled glucocorticoids].
Wada S; Kamiya S; Fukawa T
Clin Calcium; 2006 Nov; 16(11):1871-77. PubMed ID: 17079855
[TBL] [Abstract][Full Text] [Related]
42. Anabolic therapy in glucocorticoid-induced osteoporosis.
Sambrook PN
N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
[No Abstract] [Full Text] [Related]
43. Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis.
Compston JE
Eur J Endocrinol; 2023 Mar; 188(3):R46-R55. PubMed ID: 36880157
[TBL] [Abstract][Full Text] [Related]
44. In whom and how to prevent glucocorticoid-induced osteoporosis.
Adachi JD; Papaioannou A
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):1039-64. PubMed ID: 16301196
[TBL] [Abstract][Full Text] [Related]
45. Reducing fracture risk with calcium and vitamin D.
Lips P; Bouillon R; van Schoor NM; Vanderschueren D; Verschueren S; Kuchuk N; Milisen K; Boonen S
Clin Endocrinol (Oxf); 2010 Sep; 73(3):277-85. PubMed ID: 20796001
[TBL] [Abstract][Full Text] [Related]
46. Osteoporosis risk in premenopausal women.
Vondracek SF; Hansen LB; McDermott MT
Pharmacotherapy; 2009 Mar; 29(3):305-17. PubMed ID: 19249949
[TBL] [Abstract][Full Text] [Related]
47. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients.
Yosipovitch G; Hoon TS; Leok GC
Arch Dermatol; 2001 Apr; 137(4):477-81. PubMed ID: 11295929
[TBL] [Abstract][Full Text] [Related]
48. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
49. [Glucocorticoid-induced osteoporosis].
Tóth M; Tulassay Z
Orv Hetil; 2000 Jan; 141(5):219-23. PubMed ID: 10697979
[TBL] [Abstract][Full Text] [Related]
50. Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis.
Devogelaer JP; Adler RA; Recknor C; See K; Warner MR; Wong M; Krohn K
J Rheumatol; 2010 Jan; 37(1):141-8. PubMed ID: 19918047
[TBL] [Abstract][Full Text] [Related]
51. The pathogenesis, epidemiology and management of glucocorticoid-induced osteoporosis.
van Staa TP
Calcif Tissue Int; 2006 Sep; 79(3):129-37. PubMed ID: 16969593
[TBL] [Abstract][Full Text] [Related]
52. Guidance for the management of breast cancer treatment-induced bone loss: a consensus position statement from a UK Expert Group.
Reid DM; Doughty J; Eastell R; Heys SD; Howell A; McCloskey EV; Powles T; Selby P; Coleman RE
Cancer Treat Rev; 2008; 34 Suppl 1():S3-18. PubMed ID: 18515009
[TBL] [Abstract][Full Text] [Related]
53. What is new in the treatment of steroid-induced osteoporosis?
Liu RH; Werth VP
Semin Cutan Med Surg; 2007 Dec; 26(4):203-9. PubMed ID: 18395668
[TBL] [Abstract][Full Text] [Related]
54. [Current topics over updating guidelines on the management and treatment of glucocorticoid-induced osteoporosis].
Suzuki Y
Clin Calcium; 2014 Mar; 24(3):417-24. PubMed ID: 24576939
[TBL] [Abstract][Full Text] [Related]
55. [Glucocorticoid induced osteoporosis].
Anić B; Mayer M
Reumatizam; 2014; 61(2):105-12. PubMed ID: 25427404
[TBL] [Abstract][Full Text] [Related]
56. [Vitamin K2 as a potential therapeutic agent for glucocorticoid-induced osteoporosis].
Tanaka I; Oshima H
Clin Calcium; 2007 Nov; 17(11):1738-44. PubMed ID: 17982195
[TBL] [Abstract][Full Text] [Related]
57. Bisphosphonates and glucocorticoid-induced osteoporosis: cons.
Lems WF; Saag K
Endocrine; 2015 Aug; 49(3):628-34. PubMed ID: 26041376
[TBL] [Abstract][Full Text] [Related]
58. How to prevent glucocorticoid-induced osteoporosis.
Dore RK
Cleve Clin J Med; 2010 Aug; 77(8):529-36. PubMed ID: 20682515
[TBL] [Abstract][Full Text] [Related]
59. Glucocorticoid-induced osteoporosis in dermatologic practice: a review.
Khan YK; Kalaaji AN; Clarke BL
J Drugs Dermatol; 2008 Nov; 7(11):1053-9. PubMed ID: 19110736
[TBL] [Abstract][Full Text] [Related]
60. [Glucocorticoid and Bone. Updated Japanese guidelines for the management of glucocorticoid-induced osteoporosis].
Suzuki Y
Clin Calcium; 2014 Sep; 24(9):1309-18. PubMed ID: 25177003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
